Insider Trading1 Sept 2026, 03:51 pm
Symbiotec Pharmalab Closes Trading Window for Q1 FY27
AI Summary
Symbiotec Pharmalab Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is effective from September 01, 2026, and will remain in effect until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. The decision aligns with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The specific date for the board meeting to approve these financial results will be communicated separately.
Key Highlights
- Trading window closed from September 1, 2026.
- Closure is for Q1 FY27 financial results announcement.
- Applies to designated persons and immediate relatives.
- In compliance with SEBI Insider Trading Regulations.
- Board meeting date for results to be announced later.
Price Impact
More from SYMBIOTEC